CClinicalTrials.gg
CompletedNCT06937684Updated Mar 24, 2026

Early Oral Fluid Intake in Children After Day Surgery

An interventional study of Early Oral Fluid Intake and Traditional Oral Fluid Intake in Pediatric Anesthesia, Postoperative Nausea and Vomiting (PONV) and Ambulatory Surgical Procedures, sponsored by Ankara City Hospital Bilkent. Completed at 1 site in Turkey (Türkiye). Open to participants aged 1 Year to 8 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-24.

Sponsored by Ankara City Hospital Bilkent · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Nov 2024, registered Apr 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
172
Allocation
Randomized
Ages
1 Year to 8 Years
Sex
All
01

Study summary

This study investigates the safety and tolerability of early oral clear fluid intake in children aged 1-8 years undergoing elective outpatient non-gastrointestinal surgeries. Patients will be randomized to receive clear fluids either at 1 hour or 2 hours after general anesthesia. The goal is to determine whether earlier fluid intake increases the risk of postoperative vomiting (POV), or whether it can be safely tolerated in pediatric patients."

Read the detailed description

This prospective, randomized controlled clinical trial aims to evaluate the safety and tolerability of early oral clear fluid intake in children aged 1 to 8 years undergoing elective, outpatient, non-gastrointestinal surgery under general anesthesia. Recent guidelines recommend reducing preoperative and postoperative fasting durations in children to enhance recovery and well-being. Early postoperative hydration has been associated with reduced opioid requirements, faster return to normal diet and ambulation, and shorter hospital stay, without increasing the risk of postoperative nausea and vomiting (PONV).

In this study, participants will be randomly assigned to one of two groups. Group E (early group) will receive up to 10 ml/kg of clear fluids (e.g., water, clear juice) one hour after the end of anesthesia, while Group T (traditional group) will receive the same amount two hours after anesthesia. Patients will be evaluated for readiness to drink based on recovery of consciousness, protective airway reflexes, and absence of nausea or vomiting. Fluid will be administered slowly and under strict supervision by experienced staff, with emergency equipment readily available.

The incidence of vomiting will be assessed using a modified 4-point scale. Additional outcome measures include tolerability of oral fluids, time to readiness for discharge, and incidence of delayed postoperative vomiting on postoperative days 1 and 3, assessed via phone interviews with caregivers. This study seeks to provide evidence-based guidance on the optimal timing and volume of clear fluid intake in pediatric patients following ambulatory minor surgical procedures, contributing to more flexible and patient-centered perioperative fasting protocols.

02

Conditions studied

  • Pediatric Anesthesia
  • Postoperative Nausea and Vomiting (PONV)
  • Ambulatory Surgical Procedures

Keywords

  • Perioperative fasting
  • Ambulatory surgery
  • Pediatric postoperative care
  • Clear fluid intake
  • Postoperative nausea and vomiting (PONV)
  • Pediatric anesthesia
03

In context

Postoperative Nausea and Vomiting

609 studies on the registry are indexed under Postoperative Nausea and Vomiting; 109 are open to participants now.

This study's enrollment of 172 is above the median of 113 across 508 interventional studies indexed under Postoperative Nausea and Vomiting.

Browse Postoperative Nausea and Vomiting studies →

Lead sponsor

Ankara City Hospital Bilkent is the lead sponsor of 424 studies on the registry; 105 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 8 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Children aged between 1 and 8 years
  • ASA Physical Status I or II
  • Undergoing elective, outpatient, non-gastrointestinal surgery under general anesthesia
  • Expected to be discharged on the same day
  • Parent/guardian provides informed consent

Exclusion criteria

Exclusion Criteria:

  • Emergency surgeries
  • History of gastrointestinal disorders
  • History of aspiration or recurrent vomiting
  • Children with neurodevelopmental delay
  • Intraoperative complications requiring ICU admission
  • Refusal of oral intake postoperatively
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
172 participants (actual)

Study arms

  • Experimental
    Early Oral Intake Group (Group E)

    Patients in this group will receive a maximum of 10 ml/kg of clear fluids (e.g., water or clear fruit juice) starting at 1 hour after the completion of general anesthesia.

    Behavioral: Early Oral Fluid Intake

  • Active comparator
    Traditional Oral Intake Group (Group T)

    Patients in this group will receive a maximum of 10 ml/kg of clear fluids (e.g., water or clear fruit juice) starting at 2 hours after the completion of general anesthesia.

    Behavioral: Traditional Oral Fluid Intake

Interventions

  • BehavioralEarly Oral Fluid Intake

    Participants receive clear fluids up to 10 ml/kg at 1 hour after anesthesia.

  • BehavioralTraditional Oral Fluid Intake

    Participants receive clear fluids up to 10 ml/kg at 2 hours after anesthesia.

06

What researchers measure

Primary outcomes

  1. Tolerability of Early Oral Clear Fluid Intake in Children

    The number of pediatric participants who are able to tolerate clear oral fluids (up to 10 ml/kg) administered 1 hour after general anesthesia without experiencing vomiting, desaturation (SpO₂ \< 94%), or other adverse events. Tolerability is defined as successful ingestion of the planned fluid volume without signs of intolerance such as nausea, vomiting, or clinical deterioration.

    Time frame: From end of anesthesia to discharge (approximately 3-4 hours postoperative)

Secondary outcomes

  1. Total Volume of Oral Fluids Tolerated

    Amount of oral clear fluid (in ml/kg) successfully consumed by participants during the initial postoperative oral hydration attempt.

    Time frame: Within 1 and 2 hours post-anesthesia

  2. Incidence of Postoperative Vomiting

    Number of participants who experience vomiting after receiving oral clear fluids, as assessed using a 4-point modified vomiting scale from anesthesia end until discharge.

    Time frame: From end of anesthesia to discharge (within approximately 4 hours)

  3. Incidence of Postoperative Vomiting on Day 1 and Day 3

    Number of participants with parent-reported postoperative nausea assessed via structured telephone interviews conducted on postoperative day 1 and day 3.

    Time frame: Postoperative day 1 and day 3

07

Study locations

1 site
  • Ankara City Hospital Bilkent
    Ankara, 06800, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06937684
Lead sponsor
Ankara City Hospital Bilkent
Responsible party
Sponsor
First posted
Apr 22, 2025
Start date
Nov 1, 2024
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025
Last update
Mar 24, 2026

Study contacts

Feyza Sever, Assoc Prof
principal investigator · Ankara City Hospital Bilkent

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion